NCT02032095View on ClinicalTrials.gov

The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
End Stage Renal Disease
Interventions
DRUG

GB-0998

Trial Locations (1)

Unknown

Japan Blood Products Organization, Tokyo

Sponsors
All Listed Sponsors
lead

Japan Blood Products Organization

INDUSTRY